STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 90 filers reported holding STEMLINE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 11.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $479,000 | -36.0% | 99,050 | +40.6% | 0.00% | – |
| Q4 2019 | $749,000 | +29.4% | 70,450 | +26.8% | 0.00% | – |
| Q3 2019 | $579,000 | -13.1% | 55,550 | +27.8% | 0.00% | – |
| Q2 2019 | $666,000 | +15.2% | 43,450 | -3.3% | 0.00% | – |
| Q1 2019 | $578,000 | +35.4% | 44,950 | 0.0% | 0.00% | – |
| Q4 2018 | $427,000 | -45.5% | 44,950 | -4.8% | 0.00% | – |
| Q3 2018 | $784,000 | +0.1% | 47,230 | -3.3% | 0.00% | – |
| Q2 2018 | $783,000 | +5.4% | 48,830 | +0.5% | 0.00% | – |
| Q1 2018 | $743,000 | -6.8% | 48,610 | -4.8% | 0.00% | – |
| Q4 2017 | $797,000 | +63.7% | 51,080 | +16.4% | 0.00% | – |
| Q3 2017 | $487,000 | +39.9% | 43,880 | +15.8% | 0.00% | – |
| Q2 2017 | $348,000 | -7.2% | 37,880 | -13.7% | 0.00% | – |
| Q1 2017 | $375,000 | -13.4% | 43,900 | +8.7% | 0.00% | – |
| Q4 2016 | $433,000 | – | 40,400 | +100900.0% | 0.00% | – |
| Q3 2014 | $0 | – | 40 | +300.0% | 0.00% | – |
| Q2 2014 | $0 | -100.0% | 10 | -98.2% | 0.00% | – |
| Q3 2013 | $26,000 | +85.7% | 570 | 0.0% | 0.00% | – |
| Q2 2013 | $14,000 | – | 570 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|